[Federal Register Volume 85, Number 182 (Friday, September 18, 2020)]
[Notices]
[Page 58391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20599]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-706]


Bulk Manufacturer of Controlled Substances Application: Cambrex 
High Point, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cambrex High Point, Inc., has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 17, 
2020. Such persons may also file a written request for a hearing on the 
application on or before November 17, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on July 27, 2020, Cambrex High Point, Inc., 4180 
Mendenhall Oaks Parkway, High Point, North Carolina 27265-8017, applied 
to be registered as an bulk manufacturer of the following basic 
class(es) of controlled substances:

------------------------------------------------------------------------
               Controlled substance                 Drug code   Schedule
------------------------------------------------------------------------
Oxymorphone.......................................       9652         II
Noroxymorphone....................................       9668         II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-20599 Filed 9-17-20; 8:45 am]
BILLING CODE 4410-09-P